SCHEMBL21701901

SCHEMBL21701901

N#Cc1cccc(-c2ccc3c(c2)C2(c4ccccc4Sc4ccccc42)c2cc(-c4cc(-c5ccc(-c6ccccc6)cc5)nc(-c5ccccc5)n4)ccc2-3)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 2/20 0.46
PGR P06401 1/20 0.42
ALDH1A3 P47895 1/20 0.42
GABRA1 P14867 1/20 0.40
GABRG2 P18507 1/20 0.40
GABRB3 P28472 1/20 0.40
GABRA5 P31644 1/20 0.40
GABRA3 P34903 1/20 0.40
MEN1 O00255 4/20 0.39
ALDH1A1 P00352 4/20 0.39
KMT2A Q03164 4/20 0.39
LMNA P02545 3/20 0.39
CYP1A2 P05177 3/20 0.39
CYP3A4 P08684 2/20 0.39
CYP2C19 P33261 2/20 0.39
CLK4 Q9HAZ1 2/20 0.39
TSHR P16473 2/20 0.39
HSD17B10 Q99714 2/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21701791 1.00 PDK2 (0.46) PDK2PGRALDH1A3GABRA1GABRG2
SCHEMBL21701903 0.99 PDK2 (0.47) PDK2PGRALDH1A3GABRA1GABRG2
SCHEMBL21701904 0.99 PDK2 (0.47) PDK2PGRALDH1A3GABRA1GABRG2
SCHEMBL21701794 0.98 PDK2 (0.46) PDK2PGRALDH1A3GABRA1GABRG2
SCHEMBL21701902 0.97 PDK2 (0.45) PDK2PGRALDH1A3GABRA1GABRG2
SCHEMBL21701999 0.95 PDK2 (0.40) PDK2PGRALDH1A3GABRA1GABRG2
SCHEMBL21701994 0.95 PDK2 (0.40) PDK2PGRALDH1A3GABRA1GABRG2
SCHEMBL21701870 0.95 PDK2 (0.48) PDK2PGRALDH1A3GABRA1GABRG2
SCHEMBL21701798 0.94 PDK2 (0.39) PDK2PGRALDH1A3GABRA1GABRG2
SCHEMBL21702149 0.94 PDK2 (0.47) PDK2PGRALDH1A3GABRA1GABRG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200048230-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT INCLUDING SAME LG CHEM, LTD. (KR) 2020-02-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200048230-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT INCLUDING SAME CRY1, CRY2, CYP1A1 PDK2 1415/4885PGR 2183/4885ALDH1A3 249/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.